207 related articles for article (PubMed ID: 37334900)
1. PRMT5 links lipid metabolism to contractile function of skeletal muscles.
Kim KH; Jia Z; Snyder M; Chen J; Qiu J; Oprescu SN; Chen X; Syed SA; Yue F; Roseguini BT; Imbalzano AN; Hu C; Kuang S
EMBO Rep; 2023 Aug; 24(8):e57306. PubMed ID: 37334900
[TBL] [Abstract][Full Text] [Related]
2. Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth.
Liu L; Zhao X; Zhao L; Li J; Yang H; Zhu Z; Liu J; Huang G
Cancer Res; 2016 Mar; 76(5):1260-72. PubMed ID: 26759235
[TBL] [Abstract][Full Text] [Related]
3. PRMT5 mediates FoxO1 methylation and subcellular localization to regulate lipophagy in myogenic progenitors.
Kim KH; Oprescu SN; Snyder MM; Kim A; Jia Z; Yue F; Kuang S
Cell Rep; 2023 Nov; 42(11):113329. PubMed ID: 37883229
[TBL] [Abstract][Full Text] [Related]
4. PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
Yuan HF; Zhao M; Zhao LN; Yun HL; Yang G; Geng Y; Wang YF; Zheng W; Yuan Y; Song TQ; Niu JQ; Zhang XD
Acta Pharmacol Sin; 2022 Sep; 43(9):2373-2385. PubMed ID: 35046516
[TBL] [Abstract][Full Text] [Related]
5. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
[TBL] [Abstract][Full Text] [Related]
6. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
Fulton MD; Dang T; Brown T; Zheng YG
Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
[TBL] [Abstract][Full Text] [Related]
7. Protein Arginine Methyltransferase PRMT5 Regulates Fatty Acid Metabolism and Lipid Droplet Biogenesis in White Adipose Tissues.
Jia Z; Yue F; Chen X; Narayanan N; Qiu J; Syed SA; Imbalzano AN; Deng M; Yu P; Hu C; Kuang S
Adv Sci (Weinh); 2020 Dec; 7(23):2002602. PubMed ID: 33304767
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis.
Huang L; Liu J; Zhang XO; Sibley K; Najjar SM; Lee MM; Wu Q
J Biol Chem; 2018 Jul; 293(28):10884-10894. PubMed ID: 29773653
[TBL] [Abstract][Full Text] [Related]
9. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
[TBL] [Abstract][Full Text] [Related]
10. Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.
Ma D; Yang M; Wang Q; Sun C; Shi H; Jing W; Bi Y; Shen X; Ma X; Qin Z; Lin Y; Zhu L; Zhao Y; Cheng Y; Han L
Sci Adv; 2021 Mar; 7(13):. PubMed ID: 33762328
[TBL] [Abstract][Full Text] [Related]
11. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
12. NF90/NFAR (nuclear factors associated with dsRNA) - a new methylation substrate of the PRMT5-WD45-RioK1 complex.
Cox J; Esser LM; Jüdt M; Schmitz K; Reiffert K; Grimmler M; Stork B; Wesselborg S; Peter C
Biol Chem; 2022 Sep; 403(10):907-915. PubMed ID: 36040368
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice.
Katanasaka Y; Yabe H; Murata N; Sobukawa M; Sugiyama Y; Sato H; Honda H; Sunagawa Y; Funamoto M; Shimizu S; Shimizu K; Hamabe-Horiike T; Hawke P; Komiyama M; Mori K; Hasegawa K; Morimoto T
Nat Commun; 2024 Mar; 15(1):2472. PubMed ID: 38503742
[TBL] [Abstract][Full Text] [Related]
14. PRMT5 regulates ovarian follicle development by facilitating
Chen M; Dong F; Chen M; Shen Z; Wu H; Cen C; Cui X; Bao S; Gao F
Elife; 2021 Aug; 10():. PubMed ID: 34448450
[TBL] [Abstract][Full Text] [Related]
15. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
Yan F; Alinari L; Lustberg ME; Martin LK; Cordero-Nieves HM; Banasavadi-Siddegowda Y; Virk S; Barnholtz-Sloan J; Bell EH; Wojton J; Jacob NK; Chakravarti A; Nowicki MO; Wu X; Lapalombella R; Datta J; Yu B; Gordon K; Haseley A; Patton JT; Smith PL; Ryu J; Zhang X; Mo X; Marcucci G; Nuovo G; Kwon CH; Byrd JC; Chiocca EA; Li C; Sif S; Jacob S; Lawler S; Kaur B; Baiocchi RA
Cancer Res; 2014 Mar; 74(6):1752-65. PubMed ID: 24453002
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.
Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS
Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406
[TBL] [Abstract][Full Text] [Related]
17. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
[TBL] [Abstract][Full Text] [Related]
18. OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation.
Yang M; Lin X; Segers F; Suganthan R; Hildrestrand GA; Rinholm JE; Aas PA; Sousa MML; Holm S; Bolstad N; Warren D; Berge RK; Johansen RF; Yndestad A; Kristiansen E; Klungland A; Luna L; Eide L; Halvorsen B; Aukrust P; Bjørås M
Cell Rep; 2020 Mar; 30(12):4165-4178.e7. PubMed ID: 32209476
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.
Liang JH; Wang WT; Wang R; Gao R; Du KX; Duan ZW; Zhang XY; Li Y; Wu JZ; Yin H; Shen HR; Wang L; Li JY; Guo JR; Xu W
Cancer Lett; 2024 Jun; 591():216877. PubMed ID: 38615930
[TBL] [Abstract][Full Text] [Related]
20. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
